- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04950881
Cervical Vagus Nerve Block Prevents Ocularvagal Reflex
February 4, 2022 updated by: Qingxiang Mao, Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Ultrasound-guided Cervical Vagus Nerve Block Prevents Ocularvagal Reflex in Ophthalmic Surgery
In ophthalmic surgery, surgical operations such as pulling certain eye tissues or compressing the eyeball often leads to bradycardia, arrhythmia even cardiac arrest, bradypnea, nausea and vomiting and elevated blood sugar level.
The condition is called the ocularvagal reflex (OVR).
Traditionally, when the bradycardia or arrhythmia happens, the operation has to be suspended, and atropine or isoproterenol is given intravenously to treat the bradycardia.
Vagus nerve block may be an effective way to prevent and alleviate this vagal reflex.
However it is difficult to perform the nerve block with anatomical landmark (blind) methods.
In this study, the investigators used ultrasound-guided right cervical vagus nerve block to reduce the incidence of the OVR.
The researchers hypothesized that low concentrations of lidocaine or ropivacaine can block the right cervical vagus nerve and reduce the incidence of intraoperative OVR.
Researchers evaluated the changes of heart rate, blood pressure, oxygen saturation, and airway pressure in patients undergoing high-risk OVR surgery.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Chongqing
-
Chongqing, Chongqing, China, 400042
- Recruiting
- Daping Hospital, Army Medical University
-
Contact:
- Qingxiang Mao, Ph.D.
- Phone Number: 02368729729
- Email: maomaosmmu@126.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 70 years (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients received surgeries with high-risk OVR, including the strabismus surgery, the posterior scleral reinforcement, and the insertion of ocular implant.
Exclusion Criteria:
- Those who have pre-existed vocal cord damage before surgery (such as hoarseness, electronic laryngoscopy shows fixed vocal cords or arytenoid cartilage dislocation).
- Those with a history of surgery on the both sides of the neck (eg, thyroidectomy, carotid endarterectomy).
- American Society of Anesthesiologist (ASA) Grade > 3
- Patients with infection at the neck puncture site, or severe coagulation abnormalities before surgery, or a history of local anesthetic allergy, or who have a pacemaker.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Sham Comparator: Control group
Conventional monitor and treatment The surgery is performed after patient is under general anesthesia.
If patient's heart rate significantly slows down or bradycardia/arrhythmia happens, the surgeon will be asked to suspend the operation.
Meanwhile, atropine (0.01-0.02mg/kg) is given intravenously to increase the heart rate.
If atropine fails to increase the heart rate, isoproterenol (1-2 μg/per time) will be given intravenously to increase the heart rate.
|
If the OVR happens because the surgical stimulation, the operation suspends and atropine (0.01-0.02mg/kg) or isoproterenol (1-2 μg/per time)is given intravenously to increase the heart rate.
|
|
Experimental: Nerve block group
After the patient is under general anesthesia, an attending physicians perform the ultrasound-guided cervical vagus nerve block (using a 50mm Braun nerve stimulation needle, and the patients were injected with 10ml of lidocaine or ropivacaine ).
Then the operation starts.
If patient's heart rate significantly slows down or bradycardia/arrhythmia happens, the surgeon will be asked to suspend the operation.
Meanwhile, atropine (0.01-0.02mg/kg) is given intravenously to increase the heart rate.
If atropine fails to increase the heart rate, isoproterenol (1-2 μg/per time) will be given intravenously to increase the heart rate.
After endotracheal tube is removed, the patient will be followed up for next 24 hours.
|
If the OVR happens because the surgical stimulation, the operation suspends and atropine (0.01-0.02mg/kg) or isoproterenol (1-2 μg/per time)is given intravenously to increase the heart rate.
Before the operation starts, patients received the ultrasound guided vagus nerve block.
A 50mm Braun nerve stimulation needle is guided by the ultrasonic beam to insert into the carotid sheath and 10ml of lidocaine or ropivacaine is injected.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes of heart rate
Time Frame: during the operation
|
Changes of heart rate in beat per minute from Baseline
|
during the operation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes of Blood pressure
Time Frame: during the operation
|
Changes of systolic blood pressure in mmHg from Baseline
|
during the operation
|
|
Changes of Peak airway pressure
Time Frame: during the operation
|
Changes of Blood pressure in mmHg from Baseline
|
during the operation
|
|
Changes of SpO2
Time Frame: during the operation
|
Changes of SpO2 in percentage in mmHg from Baseline
|
during the operation
|
|
Nausea and vomiting in times
Time Frame: 24 hours after the operation
|
24 hours after the operation
|
|
|
Voice changes in grades (0-3)
Time Frame: 24 hours after the operation
|
Changes of Voice changes in grades (0-3) from Baseline.
0 means good, 2 means moderate change of voice, 3 means hoarse voice
|
24 hours after the operation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Casutt M, Breitenmoser I, Werner L, Seelos R, Konrad C. Ultrasound-guided carotid sheath block for carotid endarterectomy: a case series of the spread of injectate. Heart Lung Vessel. 2015;7(2):168-176.
- Arnold RW, Bond AN, McCall M, Lunoe L. The oculocardiac reflex and depth of anesthesia measured by brain wave. BMC Anesthesiol. 2019 Mar 14;19(1):36. doi: 10.1186/s12871-019-0712-z.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2021
Primary Completion (Anticipated)
December 31, 2022
Study Completion (Anticipated)
March 31, 2023
Study Registration Dates
First Submitted
June 20, 2021
First Submitted That Met QC Criteria
June 26, 2021
First Posted (Actual)
July 6, 2021
Study Record Updates
Last Update Posted (Actual)
February 21, 2022
Last Update Submitted That Met QC Criteria
February 4, 2022
Last Verified
February 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- 2021-55
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.